These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 17986503

  • 1. Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier.
    Summers M, Fisniku L, Anderson V, Miller D, Cipolotti L, Ron M.
    Mult Scler; 2008 Mar; 14(2):197-204. PubMed ID: 17986503
    [Abstract] [Full Text] [Related]

  • 2. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.
    Deloire MS, Salort E, Bonnet M, Arimone Y, Boudineau M, Amieva H, Barroso B, Ouallet JC, Pachai C, Galliaud E, Petry KG, Dousset V, Fabrigoule C, Brochet B.
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):519-26. PubMed ID: 15774439
    [Abstract] [Full Text] [Related]

  • 3. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [Abstract] [Full Text] [Related]

  • 4. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.
    Neuroimage Clin; 2015 Jun; 8():440-7. PubMed ID: 26106524
    [Abstract] [Full Text] [Related]

  • 5. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M.
    Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.
    Neuroradiology; 2001 Apr; 43(4):272-8. PubMed ID: 11338408
    [Abstract] [Full Text] [Related]

  • 8. Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis.
    Tur C, Penny S, Khaleeli Z, Altmann DR, Cipolotti L, Ron M, Thompson AJ, Ciccarelli O.
    Mult Scler; 2011 Nov; 17(11):1324-32. PubMed ID: 21803874
    [Abstract] [Full Text] [Related]

  • 9. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP, Pimentel-Silva LR, Damasceno BP, Damasceno A.
    Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
    [Abstract] [Full Text] [Related]

  • 10. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.
    Eftekhari E, Hojjat SP, Vitorino R, Carroll TJ, Cantrell CG, Lee L, Taylor MW, Morrow SA, Benhabib H, Aviv RI, Kassner A.
    Neuroradiology; 2017 Aug; 59(8):771-780. PubMed ID: 28623483
    [Abstract] [Full Text] [Related]

  • 11. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.
    Rovaris M, Iannucci G, Falautano M, Possa F, Martinelli V, Comi G, Filippi M.
    J Neurol Sci; 2002 Mar 30; 195(2):103-9. PubMed ID: 11897239
    [Abstract] [Full Text] [Related]

  • 12. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Barkhof F, Uitdehaag BMJ, Schoonheim MM, Geurts JJG.
    Brain; 2018 Sep 01; 141(9):2605-2618. PubMed ID: 30169585
    [Abstract] [Full Text] [Related]

  • 13. Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease.
    Summers M, Swanton J, Fernando K, Dalton C, Miller DH, Cipolotti L, Ron MA.
    J Neurol Neurosurg Psychiatry; 2008 Aug 01; 79(8):955-8. PubMed ID: 18339729
    [Abstract] [Full Text] [Related]

  • 14. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R, Bisecco A, Corbo D, Della Corte M, d'Ambrosio A, Docimo R, Gallo A, Esposito F, Esposito S, Cirillo M, Lavorgna L, Tedeschi G, Bonavita S.
    J Neurol; 2015 Jul 01; 262(7):1691-7. PubMed ID: 25957638
    [Abstract] [Full Text] [Related]

  • 15. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC, Cerasa A, Liguori M, Passamonti L, Condino F, Vercillo L, Valentino P, Clodomiro A, Quattrone A, Fera F.
    Brain Res; 2007 Sep 05; 1167():71-9. PubMed ID: 17689504
    [Abstract] [Full Text] [Related]

  • 16. Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg?
    Andravizou A, Siokas V, Artemiadis A, Bakirtzis C, Aloizou AM, Grigoriadis N, Kosmidis MH, Nasios G, Messinis L, Hadjigeorgiou G, Dardiotis E, Peristeri E.
    Neurol Res; 2020 Jul 05; 42(7):575-586. PubMed ID: 32427076
    [Abstract] [Full Text] [Related]

  • 17. Cognitive impairment in patients with relapsing-remitting multiple sclerosis. The correlation with MRI lesion volume.
    Karlińska I, Siger M, Lewańska M, Selmaj K.
    Neurol Neurochir Pol; 2008 Jul 05; 42(5):416-23. PubMed ID: 19105110
    [Abstract] [Full Text] [Related]

  • 18. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
    Kalinowska-Łyszczarz A, Pawlak MA, Pietrzak A, Pawlak-Buś K, Leszczyński P, Puszczewicz M, Majewski D, Paprzycki W, Kozubski W, Michalak S.
    Lupus; 2018 Apr 05; 27(4):610-620. PubMed ID: 28992796
    [Abstract] [Full Text] [Related]

  • 19. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep 05; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 20. MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis.
    Simioni S, Amarù F, Bonnier G, Kober T, Rotzinger D, Du Pasquier R, Schluep M, Meuli R, Sbarbati A, Thiran JP, Krueger G, Granziera C.
    J Neurol; 2014 Aug 05; 261(8):1606-13. PubMed ID: 24912471
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.